The current class of anti-obesity drugs is proving remarkably effective at removing excess pounds. However, a phase 3 randomized clinical trial led by researchers at Weill Cornell Medicine and NewYork-Presbyterian found that people who stopped taking the medication regained much of that weight within a year.
Opinion | Hepatitis C Vaccine Is Essential for Expediting Elimination
Pelosi is a scientific manager and researcher. Perkins is a senior advisor in governance. Remak is a patient advocate. Seid is a vaccine program lead.
July 14, 2023